GlassScriptPhysician profile
Pablo J Acebal
NPI 1598791212
$14,128.05
in general payments reported to CMS, 2019-2025
24 companies · $1,309 in 2025
The $1,309 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,939 · 2020: $1,347 · 2021: $3,958 · 2022: $2,155 · 2023: $1,429 · 2024: $991 · 2025: $1,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,402 · Travel and Lodging: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,402.44 |
| Travel and Lodging | $326.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,925.24 | 2020-2025 | Everest Spinal System, Capri Corpectomy Cage System, Ravine Lateral Access System |
| Medtronic USA, INC. | $2,283.02 | 2019-2020 | |
| Nuvasive, INC. | $642.84 | 2019-2022 | |
| Globus Medical, INC. | $634.89 | 2019-2025 | Excelsius Gps |
| Si-Bone, INC. | $559.92 | 2020-2022 | |
| Orthofix Medical, INC. | $244.83 | 2019-2025 | Cervical-Stim, Spinal-Stim |
| Medtronic, INC. | $234.03 | 2021-2022 | |
| Tela Bio, INC. | $223.09 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $191.85 | 2020-2024 | Conduit |
| Nalu Medical, INC. | $189.56 | 2021 | |
| Osseus Fusion Systems, LLC | $177.77 | 2019 | |
| Kerecis Limited | $151.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $124.80 | 2025 | Versajet, Collagenase Santyl, Oasis |
| Intrinsic Therapeutics | $94.59 | 2025 | Barricaid Acd (Annular Closure Device) |
| Ossdsign USA Incorporated | $79.55 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $67.91 | 2019 | |
| Nevro Corp. | $66.52 | 2022 | |
| Baxter Healthcare | $56.82 | 2019-2021 | |
| Abbott Laboratories | $45.18 | 2019-2021 | |
| Boston Scientific Corporation | $36.47 | 2021-2022 | |
| Glaxosmithkline, LLC. | $35.13 | 2019-2020 | |
| Silk Road Medical, INC. | $27.36 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Arkis Biosciences INC | $20.36 | 2019 | |
| Augmedics INC. | $14.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Acebal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.